EichorEICHOR
Condition: Stage Iv Non Small Cell Lung Cancer Ajcc V7 Synced from ClinicalTrials.gov · August 06, 2026

Recruiting studies: Stage Iv Non Small Cell Lung Cancer Ajcc V7

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Grid Radiation Therapy for the Treatment of Stage IV Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · Mayo Clinic · NCT06660407Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
Phase N/A · 1 location(s) · Gene Solutions · NCT06167460Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Phase 2 · 344 location(s) · National Cancer Institute (NCI) · NCT03191149De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chem
Phase 2/Phase 3 · 44 location(s) · Intergroupe Francophone de Cancerologie Thoracique · NCT05255302Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Pro
Phase 2 · 1 location(s) · University of Rochester · NCT06262321KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · 46 location(s) · Merck Sharp & Dohme LLC · NCT04165070PALACE: Cemiplimab Trial According to ctDNA Levels
Phase 2 · 20 location(s) · Fundación GECP · NCT06917573Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
NA · 7 location(s) · Swiss Cancer Institute · NCT06114108Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
NA · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT03199651A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Met
Phase 1/Phase 2 · 11 location(s) · Iovance Biotherapeutics, Inc. · NCT05361174Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Phase 2 · 71 location(s) · Iovance Biotherapeutics, Inc. · NCT04614103A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer
Phase 2 · 2 location(s) · University of Washington · NCT05242965Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
NA · 3 location(s) · University Medical Center Groningen · NCT05864794A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small C
Phase 2 · 41 location(s) · Merck Sharp & Dohme LLC · NCT06731907Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
Phase 1 · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT05681780PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer
NA · 1 location(s) · University of Washington · NCT04151940Patient-centered, Optimal Integration of Survivorship and Palliative Care
NA · 1 location(s) · Massachusetts General Hospital · NCT04900935Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
NA · 1 location(s) · Danish Lung Cancer Group · NCT03742687Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)
Phase 2/Phase 3 · 11 location(s) · Swiss Cancer Institute · NCT07149649Cisplatin (CIS) Administered As Dry Powder for Inhalation (DPI) in Patients with Stage IV Non-Small Cell Lung Cancer
Phase 1/Phase 2 · 15 location(s) · Inhatarget Therapeutics · NCT06896890Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
EARLY_Phase 1 · 1 location(s) · Emory University · NCT05493566
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.